Cargando…

Curcumin and Its Analogs in Non-Small Cell Lung Cancer Treatment: Challenges and Expectations

Researchers have made crucial advances in understanding the pathogenesis and therapeutics of non-small cell lung cancer (NSCLC), improving our understanding of lung tumor biology and progression. Although the survival of NSCLC patients has improved due to chemoradiotherapy, targeted therapy, and imm...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tang, Chunyin, Liu, Jieting, Yang, Chunsong, Ma, Jun, Chen, Xuejiao, Liu, Dongwen, Zhou, Yao, Zhou, Wei, Lin, Yunzhu, Yuan, Xiaohuan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9688036/ https://www.ncbi.nlm.nih.gov/pubmed/36358986 http://dx.doi.org/10.3390/biom12111636

Ejemplares similares

A Cyclopentanone Compound Attenuates the Over-Accumulation of Extracellular Matrix and Fibrosis in Diabetic Nephropathy via Downregulating the TGF-β/p38MAPK Axis
por: Tang, Chunyin, et al.
Publicado: (2022)

Anti-Lung Cancer Activity of the Curcumin Analog JZ534 In Vitro
por: Wu, Jianzhang, et al.
Publicado: (2015)

Curcumin and its Analogs and Carriers: Potential Therapeutic Strategies for Human Osteosarcoma
por: Lu, Ko-Hsiu, et al.
Publicado: (2023)

The curcumin analog EF24 is a novel senolytic agent
por: Li, Wen, et al.
Publicado: (2019)

Inhibition of HIV-1 by curcumin A, a novel curcumin analog
por: Kumari, Namita, et al.
Publicado: (2015)

Anti-inflammatory effects of novel curcumin analogs in experimental acute lung injury
por: Zhang, Yali, et al.
Publicado: (2015)

Evaluation of a curcumin analog as an anti-cancer agent inducing ER stress-mediated apoptosis in non-small cell lung cancer cells
por: Liu, Zhiguo, et al.
Publicado: (2013)

Synthesis and Cytotoxic Evaluation of Monocarbonyl Analogs of Curcumin as Potential Anti‐Tumor Agents
por: Pan, Zheer, et al.
Publicado: (2016)

Curcumin and Its Carbocyclic Analogs: Structure-Activity in Relation to Antioxidant and Selected Biological Properties
por: Bhullar, Khushwant S., et al.
Publicado: (2013)

Curcumin and Its Analogs as a Therapeutic Strategy in Infections Caused by RNA Genome Viruses
por: Ferreira, Leide Lene C., et al.
Publicado: (2022)

Natural product-based radiopharmaceuticals: Focus on curcumin and its analogs, flavonoids, and marine peptides
por: Wongso, Hendris
Publicado: (2022)

Effect of curcumin analogs onα-synuclein aggregation and cytotoxicity
por: Jha, Narendra Nath, et al.
Publicado: (2016)

Discovery and evaluation of asymmetrical monocarbonyl analogs of curcumin as anti-inflammatory agents
por: Zhang, Yali, et al.
Publicado: (2014)

In Vivo and In Vitro Suppression of Hepatocellular Carcinoma by EF24, a Curcumin Analog
por: Liu, Haitao, et al.
Publicado: (2012)

Promising antitumor effects of the curcumin analog DMC-BH on colorectal cancer cells
por: Liu, Gang, et al.
Publicado: (2023)

In vitro anti-Trypanosoma cruzi activity enhancement of curcumin by its monoketone tetramethoxy analog diveratralacetone
por: Souza, Julia M., et al.
Publicado: (2021)

Chemical Modification of Curcumin into Its Semi-Synthetic Analogs Bearing Pyrimidinone Moiety as Anticancer Agents
por: Afzal, Obaid, et al.
Publicado: (2022)

Application of a Novel Curcumin Analog in the Management of Diabetic Cardiomyopathy
por: Ren, Jun, et al.
Publicado: (2014)

The average life expectancy of persons with disabilities in China
por: Zhan, Peng, et al.
Publicado: (2023)

Inhibition Of JNK Phosphorylation By Curcumin Analog C66 Protects LPS-Induced Acute Lung Injury
por: Xiao, Zhongxiang, et al.
Publicado: (2019)

Autophagy and Apoptosis in Hepatocellular Carcinoma Induced by EF25-(GSH)(2): A Novel Curcumin Analog
por: Zhou, Tao, et al.
Publicado: (2014)

Potential applications of curcumin and its novel synthetic analogs and nanotechnology-based formulations in cancer prevention and therapy
por: Mimeault, Murielle, et al.
Publicado: (2011)

RNA-Seq Analysis Reveals Candidate Targets for Curcumin against Tetranychus cinnabarinus
por: Liu, Xuejiao, et al.
Publicado: (2016)

Inhibition of JNK Phosphorylation by Curcumin Analog C66 Protects LPS-Induced Acute Lung Injury [Corrigendum]
Publicado: (2022)

A Chemical Analog of Curcumin as an Improved Inhibitor of Amyloid Abeta Oligomerization
por: Orlando, Robert A., et al.
Publicado: (2012)

Bioactivities of EF24, a Novel Curcumin Analog: A Review
por: He, Yonghan, et al.
Publicado: (2018)

Curcumin and Novel Synthetic Analogs in Cell-Based Studies of Alzheimer’s Disease
por: Gagliardi, Stella, et al.
Publicado: (2018)

Selective Targeting of Cancer Cells by Oxidative Vulnerabilities with Novel Curcumin Analogs
por: Pignanelli, Christopher, et al.
Publicado: (2017)

Curcumin Analogs Reduce Stress and Inflammation Indices in Experimental Models of Diabetes
por: Biswas, Saumik, et al.
Publicado: (2019)

Curcumin and its analog alleviate diabetes-induced damages by regulating inflammation and oxidative stress in brain of diabetic rats
por: Miao, Chengfeng, et al.
Publicado: (2021)

Curcumin analog B14 has high bioavailability and enhances the effect of anti‐breast cancer cells in vitro and in vivo
por: Shen, Hui, et al.
Publicado: (2020)

A Comprehensive Review of the Application of Nanoparticles in Diabetic Wound Healing: Therapeutic Potential and Future Perspectives
por: Qin, Wenqi, et al.
Publicado: (2022)

Curcumin-Induced Global Profiling of Transcriptomes in Small Cell Lung Cancer Cells
por: Mo, Fei, et al.
Publicado: (2021)

Curcumin analog WZ26 induces ROS and cell death via inhibition of STAT3 in cholangiocarcinoma
por: Chen, Minxiao, et al.
Publicado: (2023)

In Vitro Efficacy and Molecular Mechanism of Curcumin Analog in Pathological Regulation of Spinocerebellar Ataxia Type 3
por: Wu, Yu-Ling, et al.
Publicado: (2022)

Curcumin derivative C212 inhibits Hsp90 and eliminates both growing and quiescent leukemia cells in deep dormancy
por: Liu, Bi, et al.
Publicado: (2020)

Monoketone analogs of curcumin, a new class of Fanconi anemia pathway inhibitors
por: Landais, Igor, et al.
Publicado: (2009)

Synthesis and Evaluation of a Series of Novel Asymmetrical Curcumin Analogs for the Treatment of Inflammation
por: Zhang, Yali, et al.
Publicado: (2014)

Curcumin analog, GO‐Y078, overcomes resistance to tumor angiogenesis inhibitors
por: Shimazu, Kazuhiro, et al.
Publicado: (2018)

FLLL32, a curcumin analog, ameliorates intestinal injury in necrotizing enterocolitis
por: Eckert, Jeffrey, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_2s0uj0f4t70kg1hh9n7bhhmkmn